The United States and Europe host most clinical trials?and receive the benefits of drugs even when such trials are carried out in developing countries. Eager to correct an imbalance, Mexico wants to participate more extensively. Is it ready?
Roberto Chiprut
Advertisement
Roberto Chiprut, MD, FACP, was CEO at the Instituto Mexicano de Investigación ClÃnica (IMIC), S.A. de C.V. as well as clinical professor of medicine at UCLA and Cedars Sinai Medical Center at the time of his death in 2002.
Articles by Roberto Chiprut
Advertisement
Latest Updated Articles
- Clinical Research in Mexico: An Overview
Published: June 1st 2002 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
